SCHEMBL31437046

SCHEMBL31437046

O=C1CCN(c2ccc(N3CCNCC3)c(F)c2)C(=O)N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 7/20 0.49
DDB1 Q16531 6/20 0.49
F10 P00742 1/20 0.45
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
DRD4 P21917 1/20 0.39
ALDH1A1 P00352 4/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.38
KDR P35968 1/20 0.38
GAA P10253 1/20 0.38
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27039415 0.90 CRBN (0.46) CRBNDDB1DRD3MAPTHTR1A
SCHEMBL27091768 0.88 CRBN (0.50) CRBNDDB1F10ALDH1A1LMNA
SCHEMBL25170768 0.88 CRBN (0.50) CRBNDDB1F10ALDH1A1LMNA
SCHEMBL30738820 0.88 CRBN (0.50) CRBNDDB1F10ALDH1A1LMNA
SCHEMBL27039529 0.84 DDB1 (0.49) CRBNDDB1DRD2DRD3DRD4
SCHEMBL30726420 0.84 DDB1 (0.49) CRBNDDB1DRD2DRD3DRD4
SCHEMBL31437047 0.84 DDB1 (0.46) CRBNDDB1
SCHEMBL30738791 0.83 DDB1 (0.43) CRBNDDB1F10LMNAHPGD
SCHEMBL24207123 0.83 DDB1 (0.43) CRBNDDB1F10LMNAHPGD
Hydrochloric Acid SCHEMBL30969032 0.83 DDB1 (0.48) CRBNDDB1DRD2DRD3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed